Anti-EGFR antibody [EP38Y] (Ab52894)

ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1

反应种属:Human, Mouse, Rat
抗原名称:EGFR
应用:WB, IHC, ELISA, FCM, IF/ICC, IP

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
产品形式Liquid
纯化方式Affinity purification Protein A
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
无载体蛋白No

特异性

The immunogen for this product is a synthetic phospho-peptide corresponding to residues surrounding Tyr1068 of human EGFR. After screening, clone EP38Y was found to recognize total EGFR and is not specific to phosphorylated-Tyr1068 EGFR. This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.

背景信息

Anti-EGFR antibody [EP38Y] (ab52894) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), I-ELISA, ICC/IF, IHC-P, IP and WB. Anti-EGFR antibody [EP38Y] (ab52894) was first used in a scientific publication in 2010 and has been cited over 342 times in peer reviewed journals. It's performance in Western Blot and IHC in human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-EGFR antibody [EP38Y] (ab52894) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-EGFR antibody [EP38Y] (ab52894) has been confirmed by Western Blot testing in EGFR knockout HeLa cells ( ab255385 ). Anti-EGFR antibody [EP38Y] (ab52894) has 22 independent reviews from customers. Anti-EGFR antibody [EP38Y] (ab52894) specifically detects EGFR (UniProt ID: P00533; Molecular weight: 133kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EP38Y - ab174481. Antibody clone EP38Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, Alexa Fluor ® 488, HRP, Alexa Fluor ® 594, PE, Alexa Fluor ® 555, Biotin, Alexa Fluor ® 750 ( ab192982, ab193244, ab193602, ab207870, ab208753, ab274892, ab314262, ab321669 ). The epidermal growth factor receptor (EGFR) is a critical player in oncology due to its role in cell proliferation, survival and differentiation. It is a receptor tyrosine kinase that, when mutated or overexpressed, can drive the development and progression of various cancers, including non-small cell lung cancer (NSCLC) and glioblastoma. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (382)

NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma.

NF1 缺失促进 EGFR 激活,并使 NF1 突变型黑色素瘤对 EGFR 抑制剂敏感

Ibrahim Milad, Illa-Bochaca Irineu, Jour George, Vega-Saenz de Miera Eleazar, Fracasso Joseph, Ruggles Kelly, Osman Iman, Schober Markus

Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinoma.

雄激素受体促进 AFP 阴性肝细胞癌中的花生四烯酸代谢和血管生成微环境

Lin Zhilong, Liu Xiaofei, Wang Houwei, Li Shumin, Miao Ziqiang, Yang Jing, Zhang Yuting, Lei Kai, Wu Yifan, Kang Youmei, Zheng Ruoyin, Xie Zonglin, Wen Yixi, Ren Xiaoxue, Liu Chunxiao, Cheng Alfred Sze-Lok, Xie Yubin, Chen Shuling, Kuang Ming, Peng Sui, Peng Zhenwei, Dai Zihao

Plac1(+) Tumor Cell-Treg Interplay Supports Tumorigenesis and Progression of Head and Neck Cancer.

Place1(+)肿瘤细胞-Treg相互作用支持头颈癌的肿瘤发生和进展

Meng Xiaoyan, Liu Zhonglong, Zhao Lu, Li Ran, Gan Luoman, Cao Liren, Sun Jingjing, Zhang Lingfang, He Yue

Construction of Large-Scale Bioengineered Hair Germs and In Vivo Transplantation.

大规模生物工程毛发胚芽的构建及体内移植

Chen Yangpeng, Hou Yuhui, Chen Jiejian, Bai Jiaojiao, Du Lijuan, Qiu Chen, Qi Hanzhou, Liu Xuanbei, Huang Junfei

The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC

拉泽替尼和阿米凡他单抗联合疗法作为治疗罕见EGFR突变型非小细胞肺癌的潜在策略

Seung Yeon Oh ,Sewon Park ,Seoyoung Lee ,Eun Ji Lee ,Tae Ho Kim ,Su-Jin Choi ,So Young Park ,Jae Hwan Kim ,Sun Min Lim ,Jii Bum Lee ,Byoung Chul Cho ,Min Hee Hong ,Mi Ran Yun

EGFR-mediated crosstalk between vascular endothelial cells and hepatocytes promotes Piezo1-dependent liver regeneration.

EGFR介导的血管内皮细胞与肝细胞之间的串扰促进Piezo1依赖的肝脏再生

Hu Yuelei, Du Guifang, Li Chao, Wang Rui, Liu Juan, Wang Yunfang, Dong Jiahong

LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling.

LINE1 插入 NACC2 位点会破坏 HDM2 轴并激活肺致癌信号

Bojang Pasano Jr, Wang Yingshan, Ramos Kenneth S

Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity.

乳腺癌中的核EGFR抑制NK细胞募集和细胞毒性

Escoto Angelica, Hecksel Ryan, Parkinson Chance, Crane Sara, Atwell Benjamin, King Shyanne, Ortiz Chavez Daniela, Jannuzi Alison, Sands Barbara, Bitler Benjamin G, Fehniger Todd A, Paek Andrew L, Padi Megha, Schroeder Joyce

Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop

癌症相关成纤维细胞通过 CTHRC1/糖酵解/H3K18la 正反馈环路促进 EGFR-TKI 耐药性。

Chen Zhang # ,Wenxin Zhou # ,Hai Xu # ,Jiali Xu ,Jun Li ,Xinyin Liu ,Xiyi Lu ,Jiali Dai ,Yuqin Jiang ,Wei Wang ,Erbao Zhang ,Renhua Guo

Restoration of Osimertinib sensitivity in lung cancer through BRD4 inhibitor-mediated depalmitoylation of mutant EGFR via APT1

通过 APT1 介导的 BRD4 抑制剂对突变型 EGFR 的去棕榈酰化作用,恢复肺癌对奥希替尼的敏感性

Wolong Zhou ,Shaoqiang Wang ,Zhenyu Zhang ,Linfeng Li ,Jiebo Zhu ,Hang Lin ,Heng Zhang
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 39